Novo Nordisk (NVO) FCF US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
FCF ? 47 615 000 000 47 615 000 000 64 134 000 000 64 134 000 000 70 012 000 000   35 685 000 000  
Changes by years, y/y, % +59% 0% +35% 0% +9%     +16.8%

Novo Nordisk. FCF

Novo Nordisk. FCF, changes, %

Novo Nordisk. FCF, sum by quarters

Novo Nordisk (NVO) FCF US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
FCF ? 21 542 000 000 30 342 000 000 -6 885 000 000 5 305 000 000 37 265 000 000   35 685 000 000
Changes by years, y/y, % +1% +52% -842% +73%    
Changes by quarters, q/q, % +41% -123% -177% +602%    

Novo Nordisk. FCF

Novo Nordisk. FCF, changes, y/y, %

Novo Nordisk. FCF, changes, q/q, %